Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gottlieb

Showing results (321-330 of 349) with videos related to

Pageof 35
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 2024
Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical TrialMeghan E Sise, Jose Ramon Santos, Jason D Goldman, et al.
American Journal of Respiratory and Critical Care Medicine|March 15, 2022
Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled TrialGerard J Criner, Frederick M Lang, Robert L Gottlieb, et al.
Vaccine|May 23, 2026
Consultation report - gonococcal immunoassays and standards for vaccine developmentC A MacLennan, P Davis, S L Gottlieb, et al.
Reproductive Health|November 13, 2025
Implementation of the multicountry WHO COVID-19 pregnancy cohort study: challenges and lessons learned during the pandemicMaria Laura Costa, Renato Teixeira Souza, Jose Guilherme Cecatti, et al.
Plos Medicine|July 7, 2025
Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trialsKirk U Knowlton, Lianne K Siegel, Christina E Barkauskas, et al.
JAMA|January 21, 2021
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical TrialRobert L Gottlieb, Ajay Nirula, Peter Chen, et al.
Viruses|April 27, 2024
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE TrialsCharlotte Hedskog, Christoph D Spinner, Ulrike Protzer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2005
Multistate outbreak of Listeriosis linked to turkey deli meat and subsequent changes in US regulatory policySami L Gottlieb, E Claire Newbern, Patricia M Griffin, et al.
Vaccine|July 14, 2024
Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancerPeter M Dull, Sharon L Achilles, Rafi Ahmed, et al.
Open Forum Infectious Diseases|July 20, 2021
Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day MortalitySusan A Olender, Theresa L Walunas, Esteban Martinez, et al.
Pageof 35

Showing results (321-330 of 349) with videos related to

Sort By:
Pageof 35
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 2024
Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical TrialMeghan E Sise, Jose Ramon Santos, Jason D Goldman, et al.
American Journal of Respiratory and Critical Care Medicine|March 15, 2022
Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled TrialGerard J Criner, Frederick M Lang, Robert L Gottlieb, et al.
Vaccine|May 23, 2026
Consultation report - gonococcal immunoassays and standards for vaccine developmentC A MacLennan, P Davis, S L Gottlieb, et al.
Reproductive Health|November 13, 2025
Implementation of the multicountry WHO COVID-19 pregnancy cohort study: challenges and lessons learned during the pandemicMaria Laura Costa, Renato Teixeira Souza, Jose Guilherme Cecatti, et al.
Plos Medicine|July 7, 2025
Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trialsKirk U Knowlton, Lianne K Siegel, Christina E Barkauskas, et al.
JAMA|January 21, 2021
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical TrialRobert L Gottlieb, Ajay Nirula, Peter Chen, et al.
Viruses|April 27, 2024
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE TrialsCharlotte Hedskog, Christoph D Spinner, Ulrike Protzer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2005
Multistate outbreak of Listeriosis linked to turkey deli meat and subsequent changes in US regulatory policySami L Gottlieb, E Claire Newbern, Patricia M Griffin, et al.
Vaccine|July 14, 2024
Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancerPeter M Dull, Sharon L Achilles, Rafi Ahmed, et al.
Open Forum Infectious Diseases|July 20, 2021
Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day MortalitySusan A Olender, Theresa L Walunas, Esteban Martinez, et al.
Pageof 35